3D-QSAR and Molecular Docking Studies of Triazol-Cycloalkanol Derivatives Used as Potent 3-Dehydroquinase II Inhibitors Against Mycobacterium tuberculosis
Abstract
Tuberculosis is a life threatening infectious disease caused by gram positive bacteria mycobacterium tuberculosis. Emergence of drug resistance, multi drug resistance and extensively drug resistance strain of mycobacterium make the situation more worst. It increases the mortality rate of tuberculosis patient, time duration and cost of treatment. Various inhibitors and drug molecules are designed to combat this fatal disease. Enzymes of shikimate pathway are responsible for production of essential amino acid for mycobacterium and are vital for survival of micro-organism into the host. Various enzymes of this pathway are targeted now days to find new anti-tubercular drugs. In this study we perform the 3D QSAR analysis of inhibitors of 3-Dehydroquinase (third enzyme of shikimate pathway) by k-nearest neighbour (kNN-MFA) with Step Wise (SW), Simulated Annealing (SA), Genetic Algorithm (GA) approach. A data set of 22 triazole-cycloalkanol derivative is selected and divided into training and test set molecule to generate various models. The best model contains seventeen training and five testset molecules with good internal and external predictivity. Model is statistically good as it show internal predictivity 82% (q2=0.8270) and external predictivity 94% (r2=0.9491). Model shows that the electrostatic interaction plays an important role in determining 3-dehydroquinase inhibitory activity. Designing of new inhibitor molecules were perform by substituting suitable group at places shown in model. The drug likenesses of these compounds were checked by ADME property prediction and explore their interaction with 3-Dehydroquinase II by molecular docking studies. Keywords: 3D QSAR, kNN, triazolecycloalkanol derivative, dockingCite this Article Anand Kumar Gupta, Mishra BN, Vivek Srivastava. 3D-QSAR and Molecular Docking Studies of Triazol-Cycloalkanol Derivatives Used as Potent 3-Dehydroquinase II Inhibitors against Mycobacterium tuberculosis. Research & Reviews: A Journal of Biotechnology. 2015; 5(3): 18–28p.
Veröffentlicht
Ausgabe
Rubrik
Lizenz
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
